Cytomegalovirus infection trials in Germany
3 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)
- Where
- Hamburg, Hanover, Jena, Muenster, Wuerzburg
- Age
- Up to 17 years
- People
- 80 worldwide
- Run by
- Takeda
See details and how to joinNCT05319353 · EU 2023-508988-73-00 - No phaseTaking peopleA Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
- Where
- Leipzig, Würzburg
- Age
- 18 years and over
- People
- 10 worldwide
- Run by
- Takeda
See details and how to joinNCT06243731 - Phase 3Taking peopleMultivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections
- Where
- Berlin, Dresden, Duesseldorf, Essen, Freiburg im Breisgau, Hanover, Munich, Regensburg, Tuebingen
- Age
- 2 months and over
- People
- 149 worldwide
- Run by
- Tobias Feuchtinger
See details and how to joinNCT04832607 · EU 2024-512321-84-00